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Five patients with Darier's disease and 6 patients with 
pityriasis rubra pilaris were treated with 13-cis-retinoic 
acid. Extracts of separated ep~dermis were assayed for 
extractable protein, lactic dehydrogenase, Cathepsin D, 
beta glucuronidase and neutral proteinase before begin-
ning therapy and 2, 4 and 8 weeks after therapy had 
begun. The epidermal extracts from patients with pityr-
iasis rubra pilaris before beginning therapy were similar 
to extracts from normal control patients. During the 
course of therapy with 13-cis-retinoic acid, protein ex-
tractability, lactic dehydrogenase and neutral protein-
ase did not change; there was a highly significant de-
crease in the specific activity of the lysosomal hydrolases 
Cathepsin D and beta glucuronidase. A similar but less 
dramatic fall was noted in the Darier's patients taking 
13-cis-retinoic acid. Darier's patients also had a decrease 
in neutral proteinase activity before beginning therapy; 
the specific activity of this enzyme increased during the 
course of therapy. 13-cis-retinoic acid does not induce 
clinical remission by increasing the intracellular concen-
tration of lysosomal enzymes in epidermis in vivo. 
Vitamin A is a potent lysosomallabilizer [1] which increases 
the concentration of lysosomal proteinases in cultures of em-
bryon:ic tissue [2]. Retinyl acetate induces lysosomal prolifera-
tion in cell cultures of neonatal mouse epithelium [3] and 
retinoic acid has also been shown to increase the number of 
lysosomes in cultw·es of embryonic chick skin [ 4]. 13-cis-retinoic 
acid, a vitamin A congener, has been shown to be extremely 
effective in treating such disorders of keratinization as Da:rier's 
disease, lamellar ichthyosis, and pityriasis rubra pilaris [5]. We 
investigated whether 13-cis-retinoic acid induced clinical im-
provement by producing lysosomal proliferation or activation 
in vivo. The dramatic clinical improvement in Darier's disease 
and pityriasis rubra pilaris produced by 13-cis-retinoic acid 
appears to be by a mechanism which does not include lysosomal 
proliferation or activation. 
METHODS 
Patient Selection 
Five patients with Darier's disease and 6 patients with pityriasis 
rubra piiru·is were studied. Patients were selected on the basis of 
severity of disease and refractoriness to therapy. Each was begun on 
0.5 mg/kg per day of 13-cis-retinoic acid in 2 divided oral doses. This 
dose was increased by 0.5 mg/kg per week to a maximum dose of 4.0 
mg/ kg per day which was maintained for the last 8 weeks of the 
schedule for a total of 16 weeks of therapy. The drug was discontinued 
for 8 weeks and then restarted at a dose of 2-3 mg/ kg per day. 
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BIOCHEMICAL STUDIES ON EPIDERMIS 
Preparation of Epithelial Extract 
All patients had 6-mm skin punch biopsies performed before 
beginning 13-cis-retinoic acid and at 2, 4, and 8 weeks after 
therapy had begun. In addition, patients were rebiopsied 8 
weeks after discontinuation of 13-cis-retinoic acid. Biopsies 
were obtained from the interscapular area after cleansing the 
skin with afcohol and injecting with 1% xylocaine without 
epinephrine. Whenever possible, normal appearing skin was 
obtained. As controls, 16 normal patients were biopsied in a 
similar fashion. 
The skin biopsies were coded and immediately transported 
to the laboratory on a saline sponge. The biopsies were then 
placed in 2 molar potassium bromide for 45 min (37°) [6]. The 
epidermis and dermis were mechanically separated, and the 
epidermis was then washed in phosphate buffered saline blot-
ted dry, and weighed. The usual yield was 3 mg of epid~rmis. 
The tissue was then placed in 0.3 ml of 50 mM phosphate buffer 
at pH 7.3 containing 1 M potassium chloride. The tissue was 
frozen and thawed 5 times in a dry ice-acetone slurry and the 
supernatant extract was collected by centrifugation . The epi-
thelial pellet was assayed for DNA content [7]. The supernatant 
solution was assayed for protein content by the microbiurette 
technique [8] and absorption at 280 nm assuming an absorption 
coefficient EJ~o' =1.0. Extracta bility of epidermal protein was 
cruculated as the amount of soluble protein per mg of wet 
weight epidermis. The supernatant extract solution was also 
assayed for neutral proteinase [6], Cathepsin D [6], beta glu-
curonidase [9] and lactic dehydrogenase [10]. All enzymatic 
activities were calculated on a specific activity basis. For con-
venience this is based on extractable protein by the microbi-
w-ette method in the epidermal extracts; similar results were 
obtained when DNA content of the epithelial tissue was used 
as a basis fm this calculation. Data was analyzed statistically 
using the Student's t-test. 
Assay of Neutral Proteinase Inhibitor Concentration on 
Extract 
To determine whether there were neutral proteinase inhibi-
tors in the epidermal extracts, the following experiment was 
performed. 10 ng of trypsin in phosphate buffered saline pro-
duced 300 counts/min in om standard neutral proteinase assay; 
this was midway in the linear dose response cuJ·ve of ow· assay. 
Extracts from the biopsies of 7 untreated Darier's patients and 
7 control patients were studied. Compru·able amount of protein 
ext1·act (10 ,ug/ 20,ul.) were added to the trypsin and preincubated 
for 30 min before performing the standard neutral proteinase 
assay. Results were calculated as percent inhibition per micro-
gram of skin extract. 
RESULTS 
Clinical Results 
All 5 patients with Dru·ier's disease had greater than 50% 
clinical improvement. In addition, 5 of the 6 patients with 
pityriasis rubra pilaris also had greater than 50% improvement. 
One patient with pityriasis rubra pilar is had no clinical improve-
ment and the drug was discontinued after 9 weeks of therapy. 
Maximal improvement occurred after 6 to 12 weeks of therapy. 
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All patients, except for one patient with pityriasis rubra pilaris, 
experienced relapses when th e 13-cis-retinoic acid was discon-
t inued. 
Enzymatic Studies of Pityriasis Rubra Pilcu·is 
Six patients with pityriasis rubra p iJaris were studied. All of 
these patients had diffuse disease, and biopsies were obtained 
from diseased areas. Only one of these patien ts was studied 
dUl·ing his second course of therapy. A total of 30 biopsies were 
evaluated and at least 5 biopsies were obtained at each t ime 
point. 
T he extraction method utilizing hypertonic buffer solubilized 
essentially all the enzymatic activities studied; reextraction of 
the extracted t issue pellets with detergents and repeated freez-
ing and thawing did not release further enzyme. 
Extracts of epithelium fro m patien ts with pi tyriasis r ubra 
pilaris demonstrated levels of extractable protein, lactic dehy-
drogenase and neutral proteinase which were comparable to 
control values (Fig 1). Enzymatic assays were expressed per 
microgram of protein, similar resul ts were obtained when en-
zymatic activity was expressed per microgra m of DNA in the 
epithelial pellet. P rotein extractabili ty, lactic dehydrogenase 
activity a nd neutral proteinase activi ty did not change in th e 
epidermis of patients wit h pityriasis rubra pilaris during t he 
COUTSe of therapy. By contrast, there was a dramatic m op in 
t he levels of t he 2 lysosomal hym olases, Cathepsin D and beta 
glucm onidase (Fig 2). Cathepsin D was lower than baseline at 
4 weeks (p < .025) and even lower at 8 weeks (p < .01) . 
S imilarly, beta glucuronidase was reduced at 4 weeks (p < .025) 
and even lower at 8 weeks (p < .005) when compared to base 
line values. 
Enzymatic Studies of Darier's Disease 
Five patients· wi th Darier's disease were studied. Ali 5 pa-
tients had biopsies of normal appearing skin and 3 had biopsies 
of grossly involved skin before beginning therapy. T wo of our 
patients began a second com se of therapy during the study a nd 
biopsies were obtained from all our Darier 's patients at specified 
time points except at 4 weeks of therapy. Since only 3 biopsies 
were obta ined at this tim e point, this time poin t was mopped 
from the data analysis. A total of 26 biopsies were studied . 
Darier's patients had normal levels of extracta ble protein and 
lactic dehyd1·ogenase which did not change dur ing th e course of 
therapy (Fig 3). Cathepsin D and beta glucuronidase were 
minimally lower th an control levels before beginning th erapy 
(p < .1) (Fig 4). By 8 weeks the specific activit ies of Cathepsin 
D and beta glucuronidase decreased even fmther . 
An unexpected observation was t hat neutral proteinase levels 
were significantly lower in the extracts of untreated D arier's 
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FIG 1. Protein extractabili ty, lactic dehydrogenase and neutral pro-
teinase activ ity in epidermal extracts of 16 normal control and 6 patients 
with pi tyriasis rubra pilaris before therapy and 2, 4 and 8 weeks after 
beginning therapy with 13-cis-retinoic acid (mean ± 1 SD). 
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F IG 2. Cathepsin D and beta-glucuronidase activity in epidermal 
extracts of 16 normal control patients a nd 9 patients with pi tyriasis 
rubra pilaris before therapy and 2, 4 and 8 weeks after beginning 
therapy with 13-cis- retinoic acid (mean ± 1 SD). 
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FIG 3. P rotein extractability and lactic dehydrogenase activity in 16 
normal cont rol patients and 5 Darier's patients before therapy and 2 
and 8 weeks after beginning therapy wi th 13-cis- retinoic acid (mean ± 
1 SD). 
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FIG 4. Cathepsin D and beta-glucUJ·onidase activity in 16 normal 
contro l patients and 5 Darier's patients before therapy and 2 and 8 
weeks after beginning therapy with 13-cis- retinoic acid (mean ± 1 SD ). 
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Frc 5. Neutral proteinase activity in 16 normal control patients and 
5 Darier's patients before therapy and 2 and 8 weeks after beginning 
therapy with 13-cis-retinoic acid (mean ± 1 SD) . 
patients than controls (p < .005) (Fig 5). After 8 weeks of 
therapy the neutral proteinase activity increased significantly 
over pretreatment levels (p < .05). To determine whether the 
base line diminished neutral proteinase activity was a function 
of the presence of abnormal amounts of endogenous proteinase 
inhibitors, the previously described mixing experiment was 
performed. No inhibition of trypsin activity could be demon-
strated by the extracts of the epidermis from untreated Darier's 
patients. Indeed, extracts from normal controls were slightly 
inhibitory to trypsin, whereas the extracts from Darier's pa-
tients were not. 
DISCUSSION 
These data indicate that the administration of 13-cis-retinoic 
acid to patients with Darier's disease and pityriasis rubra pilaris 
decreased the specific activity of lysosomal hydrolases in epi-
dermis to below normal levels. This effect appears to be rela-
tively specific, since there were no changes in protein extract-
ability or levels of the cytoplasmic marker enzyme lactic de-
hydrogenase. These observations could be explained by either 
decreased synthesis of lysosomal hyd1·olases or leakage of ly-
sosomal enzymes from the epidermal cells in vivo; the latter 
explanation is less likely since vitamin A usually induces in-
creases in the content of lysosomal hydrolases in cells and 
tissues at concentrations necessary for lysosomal labilization 
[2]. In patients with pityriasis rubra pilaris, there was no change 
in the levels of neutral proteinase activity. 
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Patients with Darier's disease had significant ly diminished 
levels of neutral proteinase in extracts of their epidermis. This 
diminution in enzymatic activity did not appear to be related to 
increased levels of free proteinase inhibitors. Trypsin was used 
as a neutral proteinase standard because this enzyme has bio-
chemical characteristics similar to human epidermal neutral 
proteinase [6]. There is a possibility that Darier's disease could 
have altered proteinase inhibitors in vivo but not of sufficient 
amount or specificity so that they could be detected in our 
mixing experiments. The significance of this observation is 
under study. Coincident with clinical in1provement in Daxier's 
disease was an elevation in neutral proteinase levels. This latter 
observation gives further cred ibility to t he specificity of de-
creases in lysosomal hydrolases seen with administration of 13-
cis-retinoic acid. These data indicate that 13-cis-retinoic acid 
does not increase the intracellulru· content of lysosomal hydxo-
lases but rather diminishes the content of these lysosomal 
enzy mes. We suggest that 13-cis-retinoic acid produces clinical 
improvement by altering synthetic events involved with kera-
tinization and this drug do not induce increases in the intracel-
lular content of lysosomes in vivo. 
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